The National Biopharma Mission is pleased to announce a series of webinars on Clinical Research Ethics during the autumn of 2020.
Under the umbrella of the Indo-US Vaccine Action Programme (VAP), DBT and Department of Bioethics of the U.S. National Institutes of Health Clinical Center (NIH) have initiated a collaboration to build Clinical Research Ethics capacity in India. The webinars will be organized by National Biopharma Mission on behalf of DBT. The National Biopharma Mission is a flagship initiative of the Department of Biotechnology (DBT), in partnership from World Bank, towards promotion of innovative product development and infrastructure building for biopharmaceuticals in India.
VAP is a bilateral program of the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India; and the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), USA, under implementation since July 1987. It has been recognized internationally and considered as a model bilateral programme in biomedical research, with an aim to support: novel vaccine research, human immunology, vaccine related technologies, translational research and other activities of shared scientific interest. The VAP, since its inception has supported a large number of collaborative research projects, provided training opportunities for Indian students and scientists, held bilateral workshops on vaccines and infectious diseases.
Biotech Consortium India Limited, New Delhi is assisting National Biopharma Mission in overall coordination for organizing the webinars.
The schedule of the webinar series on Clinical Research Ethics is given below: